Unichem Laboratories receives #ANDA approval from #USFDA for Losartan Potassium Tablets USP
Unichem Laboratories Ltd has received ANDA approval from the United States Food and Drug Administration (USFDA) for Losartan Potassium Tablets USP.
Losartan Potassium Tablets USP 25mg, 50mg & 100mg are therapeutically equivalent to Cozaar Tablets, 25mg, 50mg & 100mg of Merck Sharp & Dohme Corp.
Losartan Potassium is an angiotensin II receptor antagonist, indicated for Hypertension (as alone or in combination with other anithypertensive drugs), Hypertensive Patients with Left Ventricular Hypertrophy (to reduce the risk of stroke) and Nephropathy in Type 2 Diabetic Patients with Hypertension.
The product will be commercialized from Unichem’s Ghaziabad Plant. Active Pharmaceutical Ingredient will also be made in house at Pithampur API Plant.
Shares of UNICHEM LABORATORIES LTD. was last trading in BSE at Rs.303.85 as compared to the previous close of Rs. 302.9. The total number of shares traded during the day was 127045 in over 2955 trades.
The stock hit an intraday high of Rs. 311.1 and intraday low of 298. The net turnover during the day was Rs. 38897794.
Comments are closed.